The new investment will support both organic and inorganic expansion, including growth in sterile fill-finish injectables, ...

PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.

Mubadala Investment Company (Mubadala), announced the official commencement of the Al Maryah Waterfront enhancement project, ...

Weekly companies-for-sale update, featuring two newly announced deals in fire safety and drug development; KKR announces ...

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Private equity firm Partners Group on Wednesday will announce an agreement to acquire PCI Pharma Services, a Philadelphia-based provider of outsourced services to the global pharmaceutical market ...